Northrop Grumman CORP /DE/ 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NYSE
Northrop Grumman reports a 2% sales increase to $41.95 billion in 2025, but operating income growth is tempered by a significant B-21 program loss provision.
NYSE
Northrop Grumman's 2024 results showcase a robust performance with increased sales, operating income, and a growing backlog, driven by strong demand and strategic realignments.
NYSE
Northrop Grumman's 2023 10-K filing outlines the company's financial performance, strategic initiatives, and risk factors, including a significant charge on the B-21 program.